author-photo

Anna Aparicio

Memorial Sloan Kettering Cancer Center

9

Papers

534

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Erratum: Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer (eLife (2016) 5 PII: e44851)

2019 eLife
Show All
- Source
- Cite
- Save
Citations (2)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

2016 eLife
Show All
- Source
- Cite
- Save
Citations (68)
Abstract 4757: A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P6-04-12: Novel selective estrogen receptors degraders regress tumors in pre-clinical models of endocrine-resistant breast cancer

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract A4: A novel class of selective ERα degraders acts as full antagonists/ inverse agonists and displays efficacy in pre-clinical models of endocrine-resistant breast cancer and endometrial cancer

2012 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract C16: Targeting AR in castration-resistant prostate cancer: Development of ARN-509 and second-generation antiandrogen resistance models

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract A7: A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer

2011 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)